StockData
Eupraxia Pharmaceuticals Inc. logo

Eupraxia Pharmaceuticals Inc. (EPRX) bonds

EPRXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới năm tài chính 2025, năm kết thúc ngày Dec 31, 2025Last filing: 40-F on Mar 13, 2026Score 5/30
$6.62−0.72 (-9.81%)

Close on Nov 17, 2026Market cap $399.15MP/E –Yield –

Debt

Borrowings on the balance sheet, Dec 31, 2025

Eupraxia Pharmaceuticals reports no long-term debt line

Its balance sheet in XBRL does not include long-term debt, so totals and interest cost cannot be shown.

Notes and loans outstanding

As tagged in Eupraxia Pharmaceuticals's 40-F for the period ended Aug 1, 2024

Eupraxia Pharmaceuticals's filings do not break debt down by note

The debt footnote in the annual report has no machine-readable detail for individual notes, so coupons and maturities cannot be listed.

Credit facilities

Revolving credit lines and other committed borrowing capacity

FacilitySize
Convertible Debt FacilityC$12.00M

See a number that looks wrong?